Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 70351 - 70375 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Silicon dioxide	Approved	EGFL6	25975	downregulated	Silicon Dioxide results in decreased expression of EGFL6 mRNA	Xp22.2	A24196
Silicon dioxide	Approved	EGFR	1956	upregulated	Silicon Dioxide analog results in increased expression of EGFR mRNA	7p11.2	A24195
Silicon dioxide	Approved	EGFR	1956	upregulated	Silicon Dioxide results in increased expression of EGFR mRNA	7p11.2	A24200
Silicon dioxide	Approved	EGOT	100126791	upregulated	Silicon Dioxide results in increased expression of EGOT mRNA	3p26.1	A24196
Silicon dioxide	Approved	EGR1	1958	downregulated	Silicon Dioxide analog results in decreased expression of EGR1 mRNA	5q31.2	A24195
Silicon dioxide	Approved	EGR1	1958	upregulated	Silicon Dioxide analog results in increased expression of EGR1 mRNA	5q31.2	A24194
Silicon dioxide	Approved	EGR1	1958	upregulated	Silicon Dioxide results in increased expression of EGR1 mRNA	5q31.2	A24197 A24208 A24196
Silicon dioxide	Approved	EGR2	1959	downregulated	Silicon Dioxide analog results in decreased expression of EGR2 mRNA	10q21.3	A24195
Silicon dioxide	Approved	EGR2	1959	upregulated	Silicon Dioxide analog results in increased expression of EGR2 mRNA	10q21.3	A24194
Silicon dioxide	Approved	EGR3	1960	upregulated	Silicon Dioxide analog results in increased expression of EGR3 mRNA	8p21.3	A24194
Silicon dioxide	Approved	EGR3	1960	upregulated	Silicon Dioxide results in increased expression of EGR3 mRNA	8p21.3	A24197 A24196
Silicon dioxide	Approved	EGR4	1961	upregulated	Silicon Dioxide analog results in increased expression of EGR4 mRNA	2p13.2	A24194 A24195
Silicon dioxide	Approved	EHD1	10938	upregulated	Silicon Dioxide analog results in increased expression of EHD1 mRNA	11q13.1	A24195
Silicon dioxide	Approved	EHD1	10938	upregulated	Silicon Dioxide results in increased expression of EHD1 mRNA	11q13.1	A24196
Silicon dioxide	Approved	EHF	26298	downregulated	Silicon Dioxide analog results in decreased expression of EHF mRNA	11p13	A24195
Silicon dioxide	Approved	EHHADH	1962	downregulated	Silicon Dioxide analog results in decreased expression of EHHADH mRNA	3q27.2	A24195
Silicon dioxide	Approved	EHMT1-IT1	643210	upregulated	Silicon Dioxide analog results in increased expression of EHMT1-IT1 mRNA	9q34.3	A24195
Silicon dioxide	Approved	EIF5	1983	upregulated	Silicon Dioxide analog results in increased expression of EIF5 mRNA	14q32.32	A24195
Silicon dioxide	Approved	EIF6	3692	upregulated	Silicon Dioxide analog results in increased expression of EIF6 mRNA	20q11.22	A24195
Silicon dioxide	Approved	ELAC1	55520	downregulated	Silicon Dioxide results in decreased expression of ELAC1 mRNA	18q21.2	A24196
Silicon dioxide	Approved	ELANE	1991	downregulated	Silicon Dioxide analog results in decreased expression of ELANE mRNA	19p13.3	A24195
Silicon dioxide	Approved	ELF3	1999	downregulated	Silicon Dioxide analog results in decreased expression of ELF3 mRNA	1q32.1	A24195
Silicon dioxide	Approved	ELK4	2005	upregulated	Silicon Dioxide results in increased expression of ELK4 mRNA	1q32.1	A24196
Silicon dioxide	Approved	ELL2	22936	downregulated	Silicon Dioxide analog results in decreased expression of ELL2 mRNA	5q15	A24195
Silicon dioxide	Approved	ELMO1	9844	downregulated	Silicon Dioxide analog results in decreased expression of ELMO1 mRNA	7p14.2-p14.1	A24195

Displaying entries 70351 - 70375 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability